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ABSTRAK
Retinopati akibat dari radiasi (RR) ialah komplikasi yang sering berlaku kepada pesakit 
Nasopharyngeal Carcinoma (NPC). Kajian ini bertujuan untuk menentukan kaitan 
RR dengan dos radiasi yang diterima oleh pesakit NPC melalui pemeriksaan mata 
dan fundus fluorescein angiogram (FFA).  Suatu kajian rentas lintang telah dilakukan 
melibatkan pesakit NPC yang telah menerima rawatan radiasi di Klinik Onkologi, 
Universiti Kebangsaan Malaysia Medical Centre (UKMMC). Sebanyak 82 mata dari 
42 pesakit telah diperiksa dan prevalence RR didapati sebanyak 35.4%. Keterukan 
RR berkait rapat dengan dos radiasi kepada retina (Nilai Spearman correlation = 
0.48, p<0.001). Antara ciri- ciri RR yang dilihat melalui pemeriksaan FFA ialah 
salur darah telangiectatic (26.2%) dan capillary non-perfusion (14.3%). Retinal 
neovascularization dilihat berlaku kepada 10.7% dari mata yang diperiksa. Keterukan 
penglihatan didapati berkait rapat dengan keterukan RR dengan 26% daripada mata 
tersebut mempunyai penglihatan 6/18 atau lebih teruk. Lebih dari satu pertiga pesakit 
mendapat RR, dengan maculopathy radiasi sebagai penyebab yang paling kerap 
dilihat sebagai penyebab kehilangan penglihatan yang signifikan. FFA ialah alat yang 
sangat berguna untuk mengesan tanda-tanda awal RR dan maculpathy.
Kata kunci: karsinoma nasopharyng, retinopati radiasi, angiogram fluorescein fundus
ABSTRACT
Radiation retinopathy (RR) is a known complication after radiotherapy for 
Nasopharyngeal Carcinoma (NPC). This study aims to relate the relationship of 
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RR and radiation dose in patients with NPC through assessment with clinical 
funduscopy and fundus fluorescein angiogram (FFA). A cross sectional study was 
conducted on patients with NPC who had completed radiotherapy treatment in 
the Oncology Clinic, Universiti Kebangsaan Malaysia Medical Centre (UKMMC). 
Eighty two eyes of 42 patients were examined and the prevalence of RR was found 
to be 35.4%. The severity of RR is strongly associated with the dose of radiation to 
the retina (Spearman correlation value=0.48; p<0.001). The common features of 
RR assessed by FFA were telangiectatic vessels (26.2%) and capillary non-perfusion 
(14.3%). Retinal neovasularization occurred in 10.7% of eyes. The level of visual 
deterioration correlated with the severity of RR with 26% of eyes experiencing a 
visual acuity of 6/18 or worse. More than one third of patients developed RR, with 
radiation maculopathy being the commonest cause for significant visual loss. FFA 
is a useful tool in detecting early signs of radiation retinopathy and maculopathy.
Keywords: nasopharyngeal carcinoma, fluorescein fundus angiography, retinopathy, 
radiotherapy
INTRODUCTION
Nasopharyngeal carcinoma (NPC) is 
the most radiosensitive head and neck 
cancer in which radiation therapy is 
the primary treatment modality. The 
incidence rate ranges between 10 and 
50 per 100 000 (Ho 1978). Radiation 
doses between 40-70 Gy is typically 
delivered to adequately treat the 
entire tumor without damaging local 
structures such as the parotid gland 
and optic nerve (Puri et al. 2005). In 
a recent cohort of over 2500 patients 
with NPC, the control rate with these 
doses of radiation alone at 5 years was 
85%. Although the rate increases with 
higher doses, greater local side effects 
such as radiation optic neuropathy is 
commonly seen (Lee et al. 2005).
 Radiation-induced retinopathy (RR) 
is a delayed progressive retinopathy 
thought to be due to selective 
destruction of capillary endothelial 
cells leading to vascular occlusion, 
capillaries atrophy and subsequent 
ischemia (Noble & Kupersmith 1984). 
The onset varies from 1 month to 
15 years, though noticeable clinical 
signs usually appear within 3 years of 
treatment (Parsons 2004). The overall 
incidence of RR in patients with NPC 
varies with the dose of radiation (Takeda 
et al. 1999) with reported incidences as 
high as 56% with doses greater than 
50 Gy and as low as 16% with lower 
doses (Rosenblatt et al. 2003). The dose 
response curve of radiation-related 
ophthalmopathy is sigmoidal with the 
risk of RR increasing steeply above 45 
Gy and complete blindness reported 
with doses as low as 60 Gy (Parsons et 
al. 1983). RR is rarely seen below 30 Gy 
and rare cases of profound visual loss at 
these lower doses was found to be due 
to ischaemic maculopathy (Hempel & 
Hinkelbein 1993).  
 Other factors for worse RR include 
radiation fraction size, area irradiated, 
concomitant chemotherapy, pre-
existing vascular disorders like diabetes 
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mellitus and increasing age (Brown et 
al. 1982). 
 The aim of the present study was 
to determine the prevalence of RR in 
patients with NPC who have completed 
radiotherapy in a tertiary hospital in 
Malaysia and to identify if a relationship 
exists in our population that mirrors that 
of published series, between the dose 
and occurrence of RR.
MATERIALS AND METHODS
A total of 42 NPC patients who had been 
exposed to fractionated external-beam 
irradiation between 2000 and 2004 in 
the Oncology Department, Universiti 
Kebangsaan Malaysia Medical Centre 
(UKMMC) were identified and 
considered for the study following 
informed consent. Ethical approval was 
obtained from the UKMMC Ethical 
Committee prior to study initiation 
(study code: FF-019-2006).
 Patients were excluded if they had 
any of the following conditions i.e. 
significant media opacity obscuring 
adequate fundus view such as 
cataract, patients with known allergy 
to fluorescein dye, eyes with tumour 
invasion at the time of examination 
and patients who did not consent 
for fluorescent angiogram. Patients 
with diabetes mellitus (DM) were not 
excluded.
 The principal investigator (NMD) 
examined the patients which included 
assessment of visual acuity, slit lamp 
examination particularly looking for 
the presence of rubeosis iridis, corneal 
and lens clarity, tonometry and dilated 
fundus examination. Coloured fundus 
photographs were taken before the 
patient was subjected to a Fundus 
Fluorescein Angiography (FFA). The FFA 
and fundus photos were graded by a 
secondary investigator (KHS) who was 
blinded to the patient’s clinical details. 
 The radiation dose was estimated 
from the simulation and portal films and 
done in collaboration with the doctors 
and physicist from the Department of 
Radiotherapy and Oncology, UKMMC. 
When the globe lay at the border of the 
treatment field, the dose was estimated 
to be 50% of the total dose delivered. If 
the globe lay within the treatment field, 
the dose was estimated according to the 
graph obtained from a computerized 
plan. When the globe was shielded, 
the dose received by the retina was 
estimated to be between 2 to 5% of the 
total dose delivered.
 The severity of RR by clinical 
fundoscopy was graded into normal, 
non-proliferative or proliferative 
retinopathy, depending on the 
presence or absence of RR and retinal 
neovascularization. The severity of RR 
by FFA was graded as normal, mild, 
moderate, severe, and proliferative RR 
based on the criteria adopted from 
the Branch Retinal Vein Occlusion 
Study (Branch Vein Occlusion Study 
Group 1986) (Figure 1-4). Absence of 
any angiographic changes was graded 
as normal, mild RR was defined with 
the presence of changes such as 
telangiectatic vessels, microaneurysms 
and cotton wool spots, without areas of 
capillary non-perfusion, moderate RR 
was defined when there is less than 5 
disc diameter (DD) of area of capillary 
non-perfusion, severe RR was when 
there was greater than 5 DD of capillary 
non-perfusion and proliferative RR was 
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defined as presence of leaking new 
vessels. 
 Data was analyzed using SPSS 
version 12.0. Chi Square test was used 
to determine any association between 
qualitative variables. ANOVA was used 
to compare the means of more than 
variables. The data on patients with 
DM was only used when assessing 
the association between concurrent 
medical illnesses and severity of 
radiation retinopathy. Results were 
given as mean and standard deviation.
RESULTS
A total of 82 eyes from 42 patients 
were included in the study. There was 
a slight male preponderance with 24 
(57.1%) males and 18 (42.9%) females 
with a male to female ratio of 1.3:1. 
The mean age was 50.3 ± 12.1 years, 
and ranged from 20 to 72 years. There 
were 26 Chinese patients (61.9%), 15 
Malay patients (35.7%) and only one 
(2.4%) Indian patient, reflecting the 
acknowledged increased risk of NPC 
amongst the different ethnic groups.
 Among non-diabetics, the prevalence 
of eyes with RR as assessed by FFA was 
29.6% (21 eyes out of 71 eyes) with 
18.3% (13 eyes) had mild RR, 4.2% (3 
eyes) had moderate and 7% (5 eyes) 
had proliferative RR. The prevalence of 
clinically detectable RR by fundus photos 
was lower at 18.3 % (13 eyes), with 16.9 
% (12 eyes) having non-proliferative 
RR and 1.4% (1 eye) with proliferative 
RR (Figure 5 and 6). When diabetic 
patients were included, the prevalence 
of RR was slightly higher (35.4% [29 of 
82 eyes] with FFA and 25.6% [21 of 82 
eyes] with clinical grading).
 The proportion of eyes with more 
severe RR was significantly associated 
with higher doses of radiation, p < 
0.0001 (Figure 7). Half of all eyes 
receiving radiation doses less than 26 
Gy had no evidence of RR by FFA, 
and increased levels of moderate and 
proliferative RR were seen in those 
receiving doses greater than 26Gy.
 Three eyes in the study were totally 
blind with no perception of light 
(NPL) from radiation induced optic 
neuropathy. Twenty six percent of eyes 
experienced visual acuity of 6/18 or 
worse. When comparing mean visual 
acuity in Logmar to the severity of RR, 
worst RR is significantly associated with 
poorer visual acuity (p=0.003). 
 The commonest clinical feature 
seen in the studied eyes by clinical 
fundoscopy examination was hard 
exudation (14.3%) (Table 1). In contrast, 
the commonest manifestation seen on 
FFA was telangiectatic vessel (26.2%) 
(Table 2).
 Macular oedema was more common 
than macular ischaemia (13.3% vs 
4.9%).  All eyes with macula ischaemia 
received radiation dose of more than 
36 Gy. The mean radiation dose was 
higher in the ischaemic group (42Gy) 
compared to the oedema group (28Gy), 
although statistically insignificant (p = 
0.076) (Figure 8).
DISCUSSION 
RR is a potentially blinding condition 
which results from radiation delivered to 
the periorbital tissues for radiosensitive 
tumors like NPC. It is characterized 
by typical changes affecting the 
vasculature in the metabolically highly 
27
Radiation Retinopathy in Nasopharyngeal Carcinoma Med & Health 2015; 10(1): 23-31
Figure 1: Mild radiation retinopathy (Red arrows 
indicate areas of telengiectatic vessels and 
microaneurysm)
Figure 2: Moderate radiation retinopathy (Red 
arrows indicate areas of capillary non-perfusion 
the size of less than 5 disc diameter)
Figure 3: Severe radiation retinopathy (Red 
arrow indicates areas of capillary non-perfusion 
the size of which is bigger than 5 disc diameter 
Yellow arrow indicates neovascularization.
Figure 4: Proliferative radiation retinopathy 
(Red arrows denote area of capillary non-
perfusion and yellow arrows indicated florid  
neovascularization)
Figure 5: Percentage of radiation retinopathy 
and the breakdown in severity as graded by 
Fundus Fluorecein Angiogram.
Figure 6: Percentage of eyes with radiation 
retinopathy as detected by fundoscopy
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active macula, papillomacular and 
optic nerve area. Previous studies of 
RR have singled out the strongest risk 
factor to be the irradiated dose reaching 
these sensitive structures (Takeda et 
al. 1999; Rosenblatt et al. 2003). The 
present study attempted to identify the 
prevalence and clinical features of RR 
by using FFA in the local population.
 The population of patient studied 
was largely Chinese concurring with 
previous studies on NPC (Chan et al. 
2002). RR was present in about a third 
of our cases when FFA was used as the 
tool of detection. This is comparatively 
higher than previously reported studies 
where FFA was not used as the tool 
of detection (Takeda et al. 1999; 
Figure 8: Association between mean radiation 
dose and maculopathy.
Figure 7: Relationship between dose to the 
retina and severity of radiation retinopathy.
Table 1: Clinical manifestation as seen by clinical fundus examination.
Clinical feature No. of eyes (%)
Cotton wool spots 6 (7.1)
Telengiectatic vessels 3 (3.6)
Microaneurysm 10 (11.9)
Hard exudates 12 (14.3)
Neovascularization 1 (1.2)
Total 22 (38.1)
Table 2: Clinical manifestations as detected by fundus fluorescein angiogram.
Clinical feature No. of eyes (%)
Telangiectatic vessels 22 (26.2)
Capillary non perfusion 12 (14.3)
Neovascularization 9 (10.7)
Microaneurysm 13 (15.3)
Total 56 (66.5)
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Rosenblatt et al. 2003). 
 The dominant risk factor for RR in the 
present study was the dose of radiation 
to the retina. RR occurred in eyes which 
has received radiation doses of as low 
as 3.5 Gy. Other studies reported 
significant risk factors which included 
the fraction size of radiation, increasing 
age and concomitant chemotherapy 
(Brown et al. 1982).
 In the present study, the calculation 
of retinal dose is estimated from 
simulation and portal films which were 2 
dimensional. Estimation of the distance 
of the posterior border of the globe to 
the radiation field border is important 
for the calculation of the retinal radiation 
dose. Three dimensional planning was 
not available to allow greater accuracy 
of dose estimation.
 The irradiated dose to the retina 
varies as the retina is a curved planar 
structure that lines the part of the globe 
and hence different areas of the retina 
would receive different amount of 
radiation. The technique of parallel-
opposed radiation is practiced at 
UKMMC and hence the temporal retina 
receives less radiation compared to the 
nasal retina. However, in this study 
we found that most changes occured 
around the macular. This reflects the 
hypothesis that the areas most affected 
by RR are metabolically the most active, 
in this case, the macula. 
 Clinically detectable RR was present 
in 25.6% of eyes as compared to 
35.4% when FFA was used. This 
implies that if there are no changes on 
clinical fundoscopy, FFA may detect 
RR undetectable clinically such as 
areas of capillary non-perfusion. This 
would be helpful in identifying the 
cause of visual loss in cases where 
there are no detectable clinical signs. 
In most eyes with RR, vision was not 
compromised, as the pathological 
changes did not significantly involve 
the fovea or optic nerve. However, 
these patients may still develop 
proliferative RR because of extensive 
areas of peripheral capillary non-
perfusion, which spares the fovea and 
hence maintains good vision. In the 
present study, the commonest feature 
of RR is telangiectatic vessels within 
the temporal vascular arcades. These 
telangiectatic vessels are considered to 
be the hallmark of radiation damage.
 The second commonest feature was 
capillary non-perfusion, which usually 
affects the retinal area inferior to the 
inferior arcades. Because the sphenoid 
sinus, posterior ethmoid sinuses and 
posterior half of the orbit is included 
in the standard radiotherapy field, 
some part of retina may be radiated 
especially with clinical involvement of 
these structures by the tumour.
 Patients who have retinopathy 
alone without maculopathy are usually 
asymptomatic unless they have other 
complications such as optic neuropathy. 
Other causes of poor vision in our study 
was advanced proliferative retinopathy 
which may still cause poor vision 
despite treatment with laser argon 
peripheral retinal photocoagulation 
because of  ischaemic maculopathy. 
Macula oedema was found to be more 
common than macula ischaemia in 
our study. The eyes with ischaemic 
maculopathy had received a mean 
radiation dose of 42 Gy. Eyes with 
macular oedema on the other hand 
received lower radiation dose (mean 28 
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± 17.00 Gy) whereas eyes without RR 
received a mean radiation dose of 24.2 
± 16.4 Gy. As the vessels supplying the 
macula area are largely end arteries 
ending at the fovea avascular zone, 
these vessels appear to be susceptible to 
radiation related endarteritis obliterans 
(Noble & Kupersmith 1984).
 The results of this study carries the 
implication that when detected early, 
the treatment of RR may be more 
effective and brings about better visual 
outcome rather than late detection. To 
date, the treatment of proliferative RR 
and radiation maculopathy is limited 
to several modalities, such as oral 
Pentoxyfylline (Gupta et al. 2001), pan 
retinal photocoagulation (Kinyoun et 
al. 1996) and intravitreal agents such 
as triamcinolone acetonide and anti-
vascular endothelial growth factor 
(anti-VEGF). These agents may be more 
effective if RR is detected earlier.
 The study may be flawed by the 
problems associated with a retrospective 
population such as incomplete data 
collection. Furthermore, there was a 
large sampling bias as many patients 
declined to participate in this study 
and therefore it is possible that only 
those with eye symptoms will agree to 
participate. Many patients were also 
excluded because of incomplete data as 
to whether there was tumour extension 
intracranially or to the anterior nose or 
sinuses. Tumors with these extensive 
extensions require a larger treatment 
field that inevitably results in a higher 
dose to the retina. 
 A prospective observational study 
on newly diagnosed NPC in which FFA 
is performed before and serially after 
radiation would more accurately detail 
the natural history of the development 
of RR and the aggravating factors for 
the development of RR.
 Our recommendation is that patients 
who have had radiation therapy for NPC 
should have an ocular examination one 
year after the treatment and based on the 
clinical findings, be followed –up with 
yearly assessment if no clinical findings 
are noted. Should clinical findings be 
noted then an FFA is suggested, as the 
existence of neovascularisation may not 
be symptomatic and only identifiable 
by FFA.
CONCLUSION
In summary, about one third of the 
studied eyes showed features of RR. 
The dose of the radiation to the retina is 
strongly associated with the occurrence 
of radiation retinopathy. Worst vision 
is associated with more severe RR. 
However, as the initial visual acuity of 
these patients were not documented, 
the exact contribution of visual loss 
from RR is difficult to estimate.
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